Analytical Data
-
Gene name
CDS1
- Application
-
Alternative Names
CDS1; CDS; Phosphatidate cytidylyltransferase 1; CDP-DAG synthase 1; CDP-DG synthase 1; CDP-diacylglycerol synthase 1; CDS 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q92903
-
Expression Region
1-98aa
-
AA Sequence
MLELRHRGSCPGPREAVSPPHREGEAAGGDHETESTSDKETDIDDRYGDLDSRTDSDIPEIPPSSDRTPEILKKALSGLSSRWKNWWIRGILTLTMIS
-
Molecular Weight
36.52 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDS1 protein, also known as catalytic domain-specific protein 1, has garnered significant interest in the field of molecular biology and biochemistry due to its pivotal role in cellular processes. As a member of the larger family of enzymes, CDS1 is involved in various biochemical pathways, particularly those related to signal transduction and cellular responses to stress. The study of CDS1 has been accelerated by advances in recombinant DNA technology, which have allowed for the production of high-purity CDS1 proteins for functional analysis. Research has shown that CDS1 may play crucial roles in regulating cellular growth, differentiation, and apoptosis, making it a potential target for therapeutic intervention in diseases such as cancer and neurodegenerative disorders. Investigating the structural and functional characteristics of recombinant CDS1 proteins can provide insights into their enzymatic mechanisms, interaction with other cellular molecules, and their modulation under physiological and pathological conditions. Consequently, understanding CDS1 not only expands the fundamental knowledge of enzyme functions but also has implications for drug development and the design of novel therapeutic strategies. As knowledge about this protein expands, researchers aim to delineate its precise contributions to cellular metabolism and its potential as a biomarker or a therapeutic target in various diseases.
